Jan Grimm is an Associate Member of the Molecular Pharmacology Program in the Sloan Kettering Institute, an Associate Attending at Memorial Hospital and an Associate Professor at the Gerstner Sloan Kettering Graduate School of Biomedical Sciences, all of Memorial Sloan Kettering Cancer Center in New York. He is also faculty in Radiology and Pharmacology in Weil Cornell Medical College. His NIH and DoD funded Lab focuses on the development of novel and innovative imaging and therapy approaches for cancer diagnostics, such as e.g. Cerenkov Imaging. His lab was the first to utilize PET tracers clinically for Cerenkov imaging and is developing new approaches for this novel modality His lab strives to develop novel concepts on how to image biological events. This includes understanding the biological basis while simultaneously keeping clinical translatability of the projects within sight.
As an expert in the field of nanotechnology and a radiologist with experience in both clinical radiology and basic science, Dr. Grimm received his medical degree from the University of Hamburg and his PhD from the University of Schleswig-Holstein, both located in Germany. He was a postdoctoral fellow and later faculty in the Center for Molecular Imaging research at Massachusetts General Hospital in Boston from 2002-2006. Dr. Grimm has authored numerous articles, reviews and book chapters. He was also a speaker at countless seminars, lectures and symposia. He received the NIBIB Edward Nagy New Investigator Award (2014) from the NIH and was elected Member of the American Society for Clinical Investigation in 2018.
Dr. Grimm’s clinical focus is on body and nuclear imaging. He is board certified in Radiology (German and US certification) and Nuclear Medicine (in the US).